Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Whaijen Soo"'
Autor:
Craig W. Hendrix, Brent G. Petty, Amina S. Woods, Whaijen Soo, Paul S. Lietman, Frank R. Witter, Diane E. Griffin, Steven K. Kuwahara
Publikováno v:
Antiviral Research. 28:121-131
The magnitude and duration of the antiviral and clinical effect of alpha-interferon was measured in healthy volunteers. A single 3 million unit intramuscular dose of interferon was given either alone (controls) or after 72 h of concomitant medication
Publikováno v:
Pharmaceutical Sciences Encyclopedia
The continued development of biomarkers and true surrogate markers throughout the drug development value chain in the service of drug registration will remain an important activity to increase efficiency in the drug development process. Academic, pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d8b7c04212832b2c2fcfd377381dfaf
https://doi.org/10.1002/9780470571224.pse277
https://doi.org/10.1002/9780470571224.pse277
Autor:
David J. Pizzuti, Richard Reid, Whaijen Soo, Lisa H. Rutledge, Katherine H. Omoto, Mitchell D. Greenberg
Publikováno v:
American Journal of Obstetrics and Gynecology. 166:815-820
Skillful laser ablation can remove any volume of human papillomavirus—associated vulvar disease but cannot prevent reactivation of the surrounding latent viral reservoir during postoperative healing. Conversely, interferon and 5-fluorouracil are re
Autor:
Whaijen Soo
Publikováno v:
Early Phase Drug Evaluation in Man ISBN: 9781349107070
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e1710efb6ca34e5d31d8fbb16c71c71
https://doi.org/10.1007/978-1-349-10705-6_48
https://doi.org/10.1007/978-1-349-10705-6_48
Publikováno v:
Controlled Clinical Trials. 14:402
Autor:
Jacob Lalezari, David H. Henry, Cheryl Nauss-Karol, Peter T. Frame, A. Lin, Scot C. Remick, Whaijen Soo, Richard M. Olson, Judith Lieberman, Margaret A. Fischl, Stephen E. Follansbee, Miklos Salgo
Publikováno v:
Annals of Internal Medicine. 118:762
To evaluate the safety and efficacy of zalcitabine (also known as dideoxycytidine [ddC]) in patients with advanced human immunodeficiency virus (HIV) infection.Open-label, randomized study.AIDS Clinical Trials Units, university-affiliated medical cen
Autor:
Marion G. Oakes, Frederick G. Hayden, Alan J. Hay, Robert B. Belshe, Richard D. Clover, Whaijen Soo
Publikováno v:
New England Journal of Medicine. 321:1696-1702
To determine whether rimantadine can protect family members from acquiring influenza A viral illness and to assess the possible selection of drug-resistant strains of virus, we conducted a randomized, double-blind, placebo-controlled study in three c
Autor:
Lynette L. Y. Lim, Carla Pettinelli, Michael H. Grieco, Nancy Reed, Samuel A. Bozzette, Graham Ray, John C. Pottage, John M. Leedom, Herbert H. Schaumburg, William G. Powderly, Joseph Bigley, Newton E. Hyslop, Whaijen Soo, Gary L. Simon, Joseph C. Arezzo, Margaret A. Fischl, George McKinley, Raj Uttamchandani, David J. Gocke, Gail Skowron, Steven J. Sperber, James Zachary, Robert L. Murphy, Marsha L. LoFaro, Martin S. Hirsch, Lawrence D. Gelb, Stephen A. Spector, Diana Antoniskis, Douglas D. Richman, Thomas C. Merigan
Publikováno v:
Scopus-Elsevier
To determine whether alternating regimens consisting of zidovudine and 2',3'-dideoxycytidine (ddC) reduce the toxicity and maintain or increase the antiretroviral effect associated with each drug alone.An unblinded, randomized (phase II) clinical tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dab74ff748fa9d93e5e0fbae0115cf6b
http://www.scopus.com/inward/record.url?eid=2-s2.0-0027537416&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0027537416&partnerID=MN8TOARS
Autor:
Gail Skowron, Martin S. Hirsch, Herbert Schaumburg, Thomas C. Merigan, Carla P. Pettinelli, Robert T. Schooley, D. D. Richman, Whaijen Soo, Margaret A. Fischl, Raj Uttamchandani, Samuel A. Bozzette
Publikováno v:
Annals of Internal Medicine. 110:189
STUDY OBJECTIVE To determine the safety and efficacy of dideoxycytidine in patients with the acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. DESIGN A partially randomized phase I and II outpatient, dose-ranging study. SETT